Tuesday 3 November 2026 Export ELV’s income statement to Excel — free account

Elevance Health, Inc.

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.

Revenue: +1.42%
EPS: +17.9%
Free cash flow: +29.0%
Total debt: −3.65%

Quarter to September 2026, against a year earlier

414.18 0.58 +0.14%

Follow ELV

Alert me

Market cap: $89.4B
P/E: 17.7×
Fwd P/E: 18.7×
Dividend yield: 1.66%
F-score: 6/9
Altman Z: 3.09
Beneish M: −2.26
Dividend safety: 96/100

Overview Business Profile Earnings & Analysis Segments Filings

Elevance Health, Inc. 10-Q filed Oct 21, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed Oct 21, 2026 · accepted 2:14 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 21, 2025: 37 added · 35 removed · 44 modified; 30 with only figures updated

Elevance Health, Inc. 10-Q filed Oct 21, 2026

What changed

Stockrow Weekly